Opportunity Information: Apply for PAR 09 247

  • The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
  • This funding opportunity was created on Aug 16, 2012 and posted on Aug 11, 2009.
  • Applicants must submit their applications by Aug 17, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses Independent school districts State governments City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 09 247

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)" (Funding Opportunity Number PAR 09-247) is a National Institutes of Health discretionary grant designed to support add-on, or "ancillary," research projects that leverage the infrastructure, participants, specimens, and data already being collected in large, ongoing clinical research efforts. The central idea is to fund new, well-focused research questions that can be answered efficiently by building on an existing major study, rather than starting an entirely new trial or cohort from scratch. These ancillary projects are meant to produce additional scientific value from established clinical research platforms, especially when the proposed work can be integrated into ongoing operations such as follow-up visits, specimen collection schedules, or established data systems.

The FOA specifically targets ancillary studies connected to major clinical research studies, including clinical trials, epidemiologic studies, and disease databases. In this context, "major" studies include multi-center investigations, national databases, and Phase 3 clinical trials. The primary emphasis is on studies supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the announcement points investigators to an NIDDK webpage listing example eligible major studies. At the same time, the FOA is open to ancillary studies that plug into major clinical research studies supported by other NIH Institutes and Centers, other government agencies, or even private-sector efforts, as long as the ancillary project clearly advances the NIDDK mission. In practical terms, that means the science needs to align with NIDDK priority areas such as diabetes, digestive diseases, kidney and urologic diseases, obesity and nutrition-related research areas within its scope, and other NIDDK-supported scientific domains described on the institute's research webpage.

Funding is provided through the NIH Research Project Grant (R01) mechanism. That indicates the program expects a full, hypothesis-driven research plan with clear aims, strong scientific rationale, and a feasible approach, comparable to standard R01 expectations, but with added emphasis on how the work will integrate with the parent study and why the parent study is essential for the proposed aims. Because these are ancillary studies, successful applications typically need to demonstrate practical compatibility with the existing clinical study (for example, minimal disruption to ongoing trial operations, realistic additional burden on participants and sites, and a clear plan for accessing data/specimens). Although the provided summary text does not list detailed budget limits or project period caps, the R01 mechanism generally supports multi-year projects and substantial research activity when justified.

The opportunity is categorized under the "Food and Nutrition" and "Health" activity areas and is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). It does not require cost sharing or matching, which reduces barriers for applicants who may not have institutional funds available to commit to the project. The sponsoring agency is the NIH.

Eligibility is broad and includes many common NIH applicant types: public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and a wide range of governmental entities (state, county, city/township, special district governments, and independent school districts). The eligibility language also explicitly includes various mission-driven and community-based organizations and institution types such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, tribal governments and tribal organizations, U.S. territories and possessions, and faith-based or community-based organizations. Notably, the announcement also indicates that non-U.S. entities (foreign organizations) and regional organizations may be eligible, which can be important for ancillary work tied to international cohorts or global multicenter studies, assuming the project still fits the NIDDK mission and meets NIH policy requirements.

From an applicant's perspective, the key requirement embedded throughout the description is that the proposed ancillary study must be scientifically compelling and mission-relevant to NIDDK, and it must be anchored to an existing major clinical research study in a way that is both feasible and value-added. In other words, reviewers would be looking for a clear explanation of why the parent study provides a unique or cost-effective opportunity, what incremental procedures or analyses will be done, how the ancillary study will coordinate with the parent study leadership and operations, and what new knowledge will be generated that would not be achievable (or would be far less efficient) without leveraging that ongoing major study.

Administrative details included in the source data show the FOA was originally posted on August 11, 2009, with later record creation dated August 16, 2012. The listed original closing date was September 7, 2012, with a current closing date of August 17, 2012, and an archive date of September 17, 2012. The full announcement was made available through the NIH grants policy/guide page associated with PAR 09-247, and the contact provided for access or linking issues is the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV).

FAQs: Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) (PAR 09-247)

What is this grant opportunity?

This is an NIH discretionary grant opportunity titled "Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)" (Funding Opportunity Number PAR 09-247). It supports add-on ("ancillary") research projects that use the infrastructure, participants, specimens, and/or data already being collected in large, ongoing clinical research studies.

What does "ancillary study" mean in this FOA?

An ancillary study is a new, well-focused research project that is attached to an existing major clinical research study. Instead of starting a brand-new clinical trial or cohort, the ancillary project leverages what is already in place (such as scheduled follow-up visits, specimen collection routines, or established data systems) to answer additional scientific questions efficiently.

What is the main goal of funding ancillary studies?

The goal is to generate additional scientific value from established clinical research platforms by supporting new, hypothesis-driven questions that can be addressed effectively using ongoing study operations, participants, specimens, and/or data.

What types of "major" clinical research studies can an ancillary project be linked to?

The FOA targets ancillary studies connected to major clinical research studies, including clinical trials, epidemiologic studies, and disease databases. Examples of "major" studies include multi-center investigations, national databases, and Phase 3 clinical trials.

Does the parent (major) study have to be funded by NIDDK?

No. While the primary emphasis is on major studies supported by NIDDK (and the FOA points to an NIDDK webpage listing examples of eligible major studies), ancillary studies may also be attached to major studies supported by other NIH Institutes and Centers, other government agencies, or private-sector efforts, as long as the ancillary project clearly advances the NIDDK mission.

What does it mean for an ancillary study to "advance the NIDDK mission"?

It means the scientific aims of the ancillary study must align with NIDDK priority areas and scientific domains, such as diabetes, digestive diseases, kidney and urologic diseases, obesity, nutrition-related research areas within NIDDK's scope, and other NIDDK-supported areas described on the institute's research webpage.

What grant mechanism is used for this opportunity?

Funding is provided through the NIH Research Project Grant (R01) mechanism.

What level of research plan is expected under the R01 mechanism for this FOA?

The R01 mechanism signals expectations for a full, hypothesis-driven research plan with clear aims, a strong scientific rationale, and a feasible approach. For this FOA, there is additional emphasis on how the ancillary study integrates with the parent study and why the parent study is essential for accomplishing the proposed aims.

What kinds of integration with the parent study are reviewers likely to care about?

Based on the FOA description, strong applications typically show practical compatibility with the ongoing clinical study, such as minimal disruption to parent study operations, realistic added burden on participants and sites, and a clear plan for accessing needed data and/or specimens. Applications should explain how coordination with parent study leadership and operations will work.

Is this opportunity limited to specific activity areas?

The opportunity is categorized under the "Food and Nutrition" and "Health" activity areas.

What CFDA number is associated with this grant?

The CFDA number listed is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).

Is cost sharing or matching required?

No. The opportunity does not require cost sharing or matching.

Who is the sponsoring agency?

The sponsoring agency is the National Institutes of Health (NIH).

What organizations are eligible to apply?

Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (including small businesses and other for-profits); and many governmental entities (state, county, city/township, special district governments, and independent school districts).

Are minority-serving institutions and community-based organizations included in eligibility?

Yes. The eligibility language explicitly includes organizations such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, tribal governments and tribal organizations, U.S. territories and possessions, and faith-based or community-based organizations.

Are non-U.S. (foreign) organizations eligible?

Yes. The announcement indicates that non-U.S. entities (foreign organizations) and regional organizations may be eligible, which may be relevant for ancillary studies connected to international cohorts or global multicenter studies, provided the project fits the NIDDK mission and meets NIH policy requirements.

Does the FOA specify a budget limit or project period cap?

The summary provided here does not list detailed budget limits or project period caps. It notes that the R01 mechanism generally supports multi-year projects and substantial research activity when justified.

What makes an ancillary study application competitive under this FOA?

The FOA emphasizes that the ancillary project must be scientifically compelling, clearly relevant to NIDDK's mission, and firmly anchored to an existing major clinical research study in a feasible, value-added way. Reviewers would expect a clear explanation of why the parent study provides a unique or cost-effective opportunity, what incremental procedures or analyses will be done, how the ancillary work will coordinate with the parent study, and what new knowledge will be produced that would be difficult or inefficient to obtain without the parent study.

When was this FOA posted, and what are the key dates listed?

The FOA was originally posted on August 11, 2009. Administrative details also show a later record creation date of August 16, 2012. The listed original closing date was September 7, 2012, with a current closing date of August 17, 2012, and an archive date of September 17, 2012.

Where was the full announcement made available?

The full announcement was made available through the NIH grants policy/guide page associated with PAR 09-247.

Who should be contacted for access or linking issues related to the announcement?

The contact listed for access or linking issues is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Immunobiology of Xenotransplantation (U01, U19)

Previous opportunity: The Role of Human Animal Interaction in Child Health and Development (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 09 247

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 09 247) also looked into and applied for these:

Funding Opportunity
Pilot Studies for Studying the Mechanisms of Improvement in Type 2 Diabetes and Cardiovascular Risk Factors or in Cardiovascular, Lung, or Sleep Diseases after Bariatric Surgery (R01) Apply for RFA DK 09 012

Funding Number: RFA DK 09 012
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $400,000
Beta Cell Biology Consortium (U01) Apply for RFA DK 09 011

Funding Number: RFA DK 09 011
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition for Continuation of the Randomized Intervention for Vesicoureteral Reflux (RIVUR) (U01) Apply for RFA DK 09 502

Funding Number: RFA DK 09 502
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition Clinical Centers and Data Coordinating Center for the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Trial (U01) Apply for RFA DK 09 503

Funding Number: RFA DK 09 503
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition Coordinating Center For The Beta Cell Biology Consortium (U01) Apply for RFA DK 09 504

Funding Number: RFA DK 09 504
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Stimulating Hematology Investigation New Endeavors (SHINE) (R01) Apply for PAS 10 046

Funding Number: PAS 10 046
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Human Brown Adipose Tissue Methods for Measurement of Mass and Activity (R21) Apply for RFA DK 10 002

Funding Number: RFA DK 10 002
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $200,000
Planning Centers for Interdisciplinary Research in Benign Urology (IR BU) (P20) Apply for RFA DK 10 001

Funding Number: RFA DK 10 001
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $200,000
Polycystic Kidney Disease (PKD) Research and Translation Core Centers (P30) Apply for RFA DK 09 007

Funding Number: RFA DK 09 007
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Limited Competition for the Continuation of the Pediatric Acute Liver Failure Study Group (U01) Apply for RFA DK 09 505

Funding Number: RFA DK 09 505
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $700,000
Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01) Apply for RFA DK 09 506

Funding Number: RFA DK 09 506
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $600,000
NIDDK Central Repositories Non renewable Sample Access (X01) Apply for PAR 10 090

Funding Number: PAR 10 090
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
NIDDK Education Program Grants (R25) Apply for PAR 10 092

Funding Number: PAR 10 092
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
NIDDK Centers of Excellence in Molecular Hematology (P30) Apply for RFA DK 09 013

Funding Number: RFA DK 09 013
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Nutrition Obesity Research Centers (P30) Apply for RFA DK 10 003

Funding Number: RFA DK 10 003
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Child Survival Health Grants Program Apply for USAID M OAA GH HSR 10 403

Funding Number: USAID M OAA GH HSR 10 403
Agency: Agency for International Development
Category: Food and Nutrition Health
Funding Amount: $1,750,000
Grants for Research in Glomerular Diseases (R01) Apply for PA 10 113

Funding Number: PA 10 113
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R21) Apply for PA 10 128

Funding Number: PA 10 128
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $200,000
Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R01) Apply for PA 10 127

Funding Number: PA 10 127
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Adherence Studies in Adolescents with Chronic Kidney or Urologic Diseases, or Diabetes (R01) Apply for RFA DK 10 004

Funding Number: RFA DK 10 004
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 247", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.